Jacobs Levy Equity Management, Inc / EW
Jacobs Levy Equity Management, Inc’s Edwards Lifesciences Corp Position
Does Jacobs Levy Equity Management, Inc own Edwards Lifesciences Corp (EW)? Yes — 2.93M shares worth $235M (+0.99% of its 13F portfolio) as of Q1 2026, down from 3.11M shares the prior filed quarter.
Position Value
$235M
Q1 2026
Shares
2.93M
% of Portfolio
+0.99%
Quarters Held
21
currently held
Position History EW
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 2.93M | $235M | +0.99% |
| Q4 2025 | 3.11M | $266M | +1.03% |
| Q3 2025 | 3.08M | $239M | +0.95% |
| Q2 2025 | 3.44M | $269M | +1.05% |
| Q1 2025 | 4.36M | $316M | +1.25% |
| Q4 2024 | 4.62M | $342M | +1.21% |
| Q3 2024 | 3.69M | $244M | +0.94% |
| Q2 2024 | 1.09M | $100M | +0.42% |
| Q1 2024 | 1.42M | $135M | +0.60% |
| Q4 2023 | 2.39M | $183M | +0.92% |
| Q3 2023 | 2.24M | $156M | +0.92% |
| Q2 2023 | 1.66M | $157M | +0.90% |
| Q1 2023 | 287.4K | $24M | +0.15% |
| Q4 2022 | 204.4K | $15M | +0.10% |
| Q1 2021 | 3.1K | $262,000 | 0.00% |
| Q4 2020 | 7.9K | $721,000 | +0.01% |
| Q3 2020 | 78.1K | $6M | +0.06% |
| Q2 2020 | 25.3K | $2M | +0.02% |
| Q1 2020 | 1.2K | $230,000 | 0.00% |
| Q4 2019 | 1.2K | $285,000 | 0.00% |
| Q3 2019 | 24.3K | $5M | +0.07% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Jacobs Levy Equity Management, Inc’s full portfolio or all institutional holders of EW.